Bioloxía do Linfocito
BioLinfo
![Foto de Bioloxía do Linfocito](/img/grupo.png)
![Foto de Instituto de Investigación Sanitaria de Santiago de Compostela](/img/noimage_org.png)
Instituto de Investigación Sanitaria de Santiago de Compostela
Santiago de Compostela, EspañaPublicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Santiago de Compostela (39)
2024
-
Comment on Lai et al. Dipeptidyl Peptidase 4 Stimulation Induces Adipogenesis-Related Gene Expression of Adipose Stromal Cells. Int. J. Mol. Sci. 2023, 24, 16101
International Journal of Molecular Sciences
-
New Vaccines for Chronic Respiratory Patients
Archivos de Bronconeumologia
-
Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy
Cancers, Vol. 16, Núm. 13
-
Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 656-666
2023
-
A Study of the Prevalence of Asthma in the General Population in Spain
Open Respiratory Archives, Vol. 5, Núm. 2
-
Criteria to evaluate efficacy of biologics in asthma: a Global Asthma Association survey
Expert Review of Respiratory Medicine, Vol. 17, Núm. 6, pp. 507-516
-
Does asthma-bronchiectasis overlap syndrome (ABOS) really exist?
Journal of Asthma, Vol. 60, Núm. 11, pp. 1935-1941
-
Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 281-288
-
Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231
-
Omalizumab in Severe Asthma: Effect on Oral Corticosteroid Exposure and Remodeling. A Randomized Open-Label Parallel Study
Drugs, Vol. 83, Núm. 12, pp. 1111-1123
-
Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study
Journal of Medical Virology, Vol. 95, Núm. 7
-
Real-Life Effectiveness of Benralizumab, Mepolizumab and Omalizumab in Severe Allergic Asthma Associated with Nasal Polyps
Clinical Reviews in Allergy and Immunology, Vol. 64, Núm. 2, pp. 179-192
-
Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 1, pp. 141-155
2022
-
CD26 and Cancer
Cancers
-
Development and Validation of a Knowledge, Attitude and Practice Questionnaire on Antibiotic Use in Arabic and French Languages in Lebanon
International Journal of Environmental Research and Public Health, Vol. 19, Núm. 2
-
Gastroesophageal reflux disease and asthma exacerbation: A systematic review and meta-analysis
Pediatric Allergy and Immunology, Vol. 33, Núm. 1
-
Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients
Archivum Immunologiae et Therapiae Experimentalis, Vol. 70, Núm. 1
-
With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence
Archivos de Bronconeumologia
-
[Translated article] With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence
Archivos de Bronconeumologia
2021
-
Blood eosinophil count as predictor of asthma exacerbation. A meta-analysis
Pediatric Allergy and Immunology, Vol. 32, Núm. 3, pp. 465-478